Federated Hermes, Inc. Liva Nova PLC Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Liva Nova PLC stock. As of the latest transaction made, Federated Hermes, Inc. holds 141,070 shares of LIVN stock, worth $6.79 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

141,070

Previous 139,331 1.25%

Holding current value

$6.79 Million

Previous $7.64 Million 3.02%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$43.38 - $54.59 $75,437 - $94,932	1,739 Added 1.25%	141,070 $7.41 Million
Q2 2024 Aug 08, 2024	SELL	$51.76 - $64.15 $329,400 - $408,250	-6,364 Reduced 4.37%	139,331 $7.64 Million
Q1 2024 May 14, 2024	SELL	$48.6 - $57.12 $42,962 - $50,494	-884 Reduced 0.6%	145,695 $8.15 Million
Q4 2023 Jan 31, 2024	SELL	$43.45 - $53.66 $229,937 - $283,968	-5,292 Reduced 3.48%	146,579 $7.58 Million
Q3 2023 Nov 13, 2023	SELL	$50.12 - $58.87 $1.1 Million - $1.29 Million	-21,959 Reduced 12.63%	151,871 $8.03 Million
Q2 2023 Aug 14, 2023	BUY	$42.28 - $51.43 $3.38 Million - $4.11 Million	79,870 Added 85.0%	173,830 $8.94 Million
Q1 2023 May 08, 2023	SELL	$40.84 - $58.14 $3.95 Million - $5.63 Million	-96,840 Reduced 50.75%	93,960 $4.09 Million
Q4 2022 Feb 13, 2023	SELL	$43.88 - $56.16 $1.12 Million - $1.43 Million	-25,419 Reduced 11.76%	190,800 $10.6 Million
Q3 2022 Nov 14, 2022	SELL	$48.37 - $66.5 $572,168 - $786,628	-11,829 Reduced 5.19%	216,219 $11 Million
Q2 2022 Aug 15, 2022	SELL	$57.25 - $86.63 $987,963 - $1.49 Million	-17,257 Reduced 7.03%	228,048 $14.2 Million
Q1 2022 May 13, 2022	SELL	$71.02 - $86.99 $6.98 Million - $8.55 Million	-98,243 Reduced 28.6%	245,305 $20.1 Million
Q4 2021 Feb 14, 2022	BUY	$76.72 - $92.68 $431,089 - $520,768	5,619 Added 1.66%	343,548 $30 Million
Q3 2021 Nov 15, 2021	SELL	$76.02 - $88.62 $319,131 - $372,026	-4,198 Reduced 1.23%	337,929 $26.8 Million
Q2 2021 Aug 16, 2021	SELL	$73.44 - $87.01 $6.96 Million - $8.25 Million	-94,835 Reduced 21.7%	342,127 $28.8 Million
Q1 2021 May 13, 2021	SELL	$62.9 - $82.41 $11.1 Million - $14.5 Million	-176,384 Reduced 28.76%	436,962 $32.2 Million
Q4 2020 Feb 12, 2021	SELL	$46.01 - $68.74 $395,363 - $590,682	-8,593 Reduced 1.38%	613,346 $40.6 Million
Q3 2020 Nov 12, 2020	SELL	$41.91 - $57.81 $37,257 - $51,393	-889 Reduced 0.14%	621,939 $28.1 Million
Q2 2020 Aug 13, 2020	SELL	$39.87 - $56.9 $13.9 Million - $19.9 Million	-349,546 Reduced 35.95%	622,828 $30 Million
Q1 2020 May 13, 2020	BUY	$34.22 - $76.49 $723,137 - $1.62 Million	21,132 Added 2.22%	972,374 $44 Million
Q4 2019 Feb 14, 2020	SELL	$68.92 - $85.27 $3.27 Million - $4.05 Million	-47,443 Reduced 4.75%	951,242 $71.8 Million
Q3 2019 Nov 14, 2019	BUY	$71.74 - $86.35 $8.8 Million - $10.6 Million	122,677 Added 14.0%	998,685 $73.7 Million
Q2 2019 Aug 14, 2019	BUY	$66.45 - $97.36 $21.9 Million - $32.2 Million	330,235 Added 60.51%	876,008 $63 Million
Q1 2019 May 10, 2019	SELL	$86.15 - $100.49 $1.84 Million - $2.15 Million	-21,391 Reduced 3.77%	545,773 $53.1 Million
Q4 2018 Feb 13, 2019	BUY	$84.14 - $125.42 $822,720 - $1.23 Million	9,778 Added 1.75%	567,164 $51.9 Million
Q3 2018 Nov 13, 2018	BUY	$101.02 - $130.95 $52.8 Million - $68.5 Million	522,859 Added 1514.35%	557,386 $69.1 Million
Q2 2018 Aug 10, 2018	SELL	$81.75 - $105.37 $5.16 Million - $6.65 Million	-63,091 Reduced 64.63%	34,527 $3.45 Million
Q1 2018 May 09, 2018	SELL	$79.95 - $89.74 $1.51 Million - $1.7 Million	-18,932 Reduced 16.24%	97,618 $8.64 Million
Q4 2017 Feb 14, 2018	SELL	$71.8 - $88.21 $6.65 Million - $8.17 Million	-92,564 Reduced 44.26%	116,550 $0
Q3 2017 Nov 13, 2017	BUY	$60.32 - $70.06 $12.6 Million - $14.7 Million	209,114	209,114 $14.7 Million

Others Institutions Holding LIVN

# of Institutions

265

Shares Held

53M

Call Options Held

316K

Put Options Held

127K

View Full List

About LivaNova PLC

Ticker LIVN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,545,700
Market Cap $2.58B
Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...

More about LIVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Liva Nova PLC Transaction History